The import of cortisone, hydrocortisone, prednisone, and prednisolone to France shows a downward trend from 2024 to 2028, starting at $22.244 million and decreasing steadily each year. In 2023, the import value stood at $22.5 million. Year-on-year variations indicate a consistent decrease of approximately 0.75% annually. The compound annual growth rate (CAGR) over the five-year forecast period is around -0.73%, reflecting a gradual decline in imports.
Future trends to watch for include potential fluctuations in global supply chains, changes in healthcare policies, and shifts in demand due to medical advancements or alternatives. Monitoring these factors will be crucial for anticipating further changes in import needs.
